Xact Kapitalforvaltning’s Medicines Co MDCO Stock Holding History

Xact Kapitalforvaltning’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,960	Closed	-$1.19M	–	1404
2019 Q4	$1.19M	Hold	13,960	–	–	0.02%	556
2019 Q3	$698K	Hold	13,960	–	–	0.01%	733
2019 Q2	$509K	Hold	13,960	–	–	0.01%	912
2019 Q1	$390K	Hold	13,960	–	–	0.01%	1072
2018 Q4	$267K	Buy	13,960 +1,500	+12%	+$34.9K	0.01%	1298
2018 Q3	$373K	Buy	12,460 +1,000	+9%	+$37.7K	0.01%	1188
2018 Q2	$421K	Buy	11,460 +1,200	+12%	+$39K	0.01%	1074
2018 Q1	$338K	Buy	10,260 +2,300	+29%	+$71.9K	0.01%	1149
2017 Q4	$218K	Buy	+7,960	New	+$245K	0.01%	1194

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Xact Kapitalforvaltning's MDCO Position: Q1 2020 in Review

Xact Kapitalforvaltning sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 13,960 shares — an estimated $1.19M sold.

Xact Kapitalforvaltning first reported a position in MDCO in Q4 2017 and held it in 9 quarters. The position peaked at $1.19M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Xact Kapitalforvaltning reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Xact Kapitalforvaltning sold 13,960 Medicines Co shares in Q1 2020, an estimated $1.19M.
Xact Kapitalforvaltning first reported a position in Medicines Co in Q4 2017 and held it in 9 quarters.
Xact Kapitalforvaltning's Medicines Co position peaked at $1.19M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.